Cellosaurus QBC939/ADM (CVCL_LJ49)
| Cell line name | QBC939/ADM |
|---|---|
| Accession | CVCL_LJ49 |
| Resource Identification Initiative | To cite this cell line use: QBC939/ADM (RRID:CVCL_LJ49) |
| Comments | Population: Chinese. Doubling time: 32.2 hours (PubMed=20111907). Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. |
| Disease | Cholangiocarcinoma (NCIt: C4436) Cholangiocarcinoma (ORDO: Orphanet_70567) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_6942 (QBC939) |
| Sex of cell | Male |
| Age at sampling | 51Y |
| Category | Cancer cell line |
| Publications | PubMed=20111907; DOI=10.1007/s11033-010-9975-7 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q54948795 |
| Entry history | |
| Entry creation | 15-Nov-2017 |
| Last entry update | 10-Apr-2025 |
| Version number | 8 |